Capsule OEM Fill Formats Compared: Powder, Granules, Pellets and Liquid-Filled Hard Capsules
Capsules look like the simplest dosage form: put material into a shell and close it. In practice the shell is rarely what decides success; the physical form of the fill is. The same formulation can fail fill-weight variation as a direct powder and pass comfortably once granulated. A sustained release profile that a matrix powder cannot deliver may fall into place with coated pellets. On capsule programmes we settle the fill format before finalising excipients and process, because reversing that order almost always means rework. Four routes cover most of what runs on a real line.
1. Why the fill form decides the outcome
The filling machine dictates the sensitivity. Most capsule fillers meter by volume through a dosing disc or tube, so the fill weight you achieve depends on bulk density and flow rather than on any weighing step. Material that will not flow leaves the dosing bore partly empty, giving low and variable fill. Material that is very fine and light has low bulk density, so the target dose may not physically fit the shell. Material that segregates separates into coarse and fine fractions under vibration, and the assay drifts between the start and end of a run. Form also governs dissolution and stability: a hygroscopic powder in direct contact with the shell pulls water out of the gelatin and embrittles it, while oily fills soften it. Once those cause-and-effect links are clear, selection becomes straightforward.
2. Direct powder filling: when it is enough
Direct filling is the cheapest and shortest route, and its suitability comes down to a few measured properties. Flow is usually expressed as angle of repose: below about 35 degrees is considered good, above 40 needs work. Bulk density determines whether the target dose fits, and above roughly 0.4 g per ml leaves comfortable margin. A high fines fraction brings dust, wall build-up and segregation. Where flow is acceptable, the dose is moderate and the components do not differ wildly in density, a small addition of glidant such as colloidal silica plus a lubricant is usually sufficient. Three situations argue against it: very low dose with a small active fraction, where blend uniformity is hard to prove; large particle size or density differences between components, where vibration segregates the bed; and sticky or hygroscopic material, which builds up on the dosing disc and shifts fill weight.
3. Granulation: the workhorse improvement
Granulation is the standard fix, in wet and dry variants. Wet granulation binds fines into granules with a binder solution, improving flow, bulk density and content uniformity in one step while cutting dust and cross-contamination risk, which suits most botanical extracts, plant powders and multi-nutrient blends. The cost is an extra stage and a drying step, so heat-sensitive actives need the drying temperature controlled. Dry granulation by roller compaction uses pressure rather than liquid, suits material that is unstable or degrades in the presence of moisture, and is shorter, but it demands reasonable compressibility and typically leaves more fines than wet granulation. Either way the particle size distribution has to be controlled: too coarse hurts fill precision, too many fines takes you back to the direct-filling problem, so the spread is narrowed through milling and screening.
4. Pellets and modified release
When a product needs sustained release, enteric protection or taste masking, pellets are usually the only reliable answer. Drug-loaded pellets are produced by extrusion and spheronisation or in a coating pan, coated with a functional polymer, then filled to dose. The advantage is the multi-unit nature: hundreds or thousands of units release in parallel, so a coating defect on a few barely moves the overall profile, and reproducibility beats a single matrix unit by a wide margin. Pellets of different release rates can be blended in proportion to build a target curve, and enteric-coated pellets carry acid-sensitive actives through the stomach. The price is complexity, capital and lead time. Pellets flow well, but bulk density and size distribution must match the capsule size, and dosing is usually by weight rather than volume. Polymer choice and coating weight gain are the two knobs that shape the release profile.
5. Liquid and semi-solid fills
Poorly water-soluble oils, low melting point actives and fat-soluble nutrients that need better bioavailability often perform badly as powders, in both solubility and stability. Liquid-filled hard capsules are the alternative: the liquid or semi-solid matrix is filled and then sealed with a gelatin or HPMC band. Common matrices include medium chain triglycerides, vegetable oils, polyethylene glycols and hot-melt semi-solid systems. Three variables decide whether it works: fill temperature, since excessive heat damages the shell; viscosity, which drives dosing accuracy and leakage risk; and compatibility, because some surfactants and organic solvents interact with gelatin and make the shell brittle or soft. Seal integrity has to be verified through leak testing plus appearance checks under accelerated conditions, and band width and seal solution solids are monitored in line.
6. A short selection checklist
Five questions usually settle it. How large is the unit dose: large doses push you towards higher bulk density through granulation or a bigger shell. What is the material like: poor flow, segregation or stickiness points to granulation; heat sensitivity to dry granulation; oily or lipophilic actives to liquid filling. Is a release profile required: sustained, enteric or pulsatile release means pellets. What are the cost and lead-time constraints: direct filling is cheapest, granulation next, pellets the most expensive and slowest. And what equipment is actually available, since pellets need dedicated machinery and liquid filling needs a sealing unit, which narrows the field of qualified plants. Once the route is chosen, the last step is filling validation: sample across the run for fill weight variation and content uniformity, confirm the process window holds, and only then talk about commercial volumes.
Related Products
Vitamin D3 K2 with Magnesium & Zinc Softgels | VITAMIN D3+K2 MAGNESIUM+ZINC Softgels OEM | Calcium + Magnesium + Zinc + Vitamin D3 Softgels | CALCIUM+MAGNESIUM+ZINC D3 Softgel OEM
About Guangzhou Mesen Health Biotechnology Co., Ltd
Guangzhou Mesen Health Biotechnology Co., Ltd is located in the Huashan Science and Technology Park, Huadu District, Guangzhou. The company has focused on OEM and ODM services for the big health industry for nearly 20 years, operating dedicated research, production, sales and management centres, and maintaining long-term strategic partnerships with well-known Chinese medicine colleges and research institutions. Capabilities span pressed candy, gummies, capsules, solid beverages, herbal teas, plant beverages, protein powders, dietary supplements and enzyme jelly - from formulation development through contract manufacturing. For details on minimum order quantities, sampling lead times and quotations, see our manufacturing advantages and product range, or contact us for a tailored proposal.
Further Reading
